Clinical Trial Update: A Longitudinal, Observational Study of Primary Ciliary Dyskinesia in Adults

View source ↗

Summary

A longitudinal observational study of adults with Primary Ciliary Dyskinesia sponsored by ReCode Therapeutics, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ciliary Dyskinesia

Snippet

Sponsor: ReCode Therapeutics | Conditions: Primary Ciliary Dyskinesia | Status: ACTIVE_NOT_RECRUITING